About Nagi Bioscience
Nagi Bioscience is a company based in Lausanne (Switzerland) founded in 2017 by Matteo Cornaglia.. Nagi Bioscience has raised $1.84 million across 2 funding rounds from investors including Zurcher Kantonalbank, Nest Sammelstiftung and Verve Ventures. Nagi Bioscience offers products and services including SydLab™ One, Contract Laboratory Solutions, and Organism-on-Chip Technology. Nagi Bioscience operates in a competitive market with competitors including Biocytogen, Applied StemCell, Interius Biotherapeutics, GemPharmatech and Business Catalyst, among others.
- Headquarter Lausanne, Switzerland
- Founders Matteo Cornaglia
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nagi Bioscience Sa
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.84 M (USD)
in 2 rounds
-
Latest Funding Round
$1.84 M (USD), Seed
Dec 20, 2019
-
Investors
Zurcher Kantonalbank
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nagi Bioscience
Nagi Bioscience offers a comprehensive portfolio of products and services, including SydLab™ One, Contract Laboratory Solutions, and Organism-on-Chip Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated high-content platform for drug testing using C. elegans nematodes.
End-to-end solutions for aging, toxicity, and neurodegenerative studies.
Innovative system for ethical testing of chemicals and drugs.
Unlock access to complete
Unlock access to complete
Funding Insights of Nagi Bioscience
Nagi Bioscience has successfully raised a total of $1.84M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.84 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $1.8M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Seed - Nagi Bioscience | Valuation | Zurcher Kantonalbank , Nest |
|
| Jun, 2018 | Amount | Seed - Nagi Bioscience | Valuation | MassChallenge |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nagi Bioscience
Nagi Bioscience has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Zurcher Kantonalbank, Nest Sammelstiftung and Verve Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on science and tech-driven startups
|
Founded Year | Domain | Location | |
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Founded Year | Domain | Location | |
|
Commercial banking services are provided across Switzerland by Zurcher Kantonalbank.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nagi Bioscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nagi Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nagi Bioscience Comparisons
Competitors of Nagi Bioscience
Nagi Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, Applied StemCell, Interius Biotherapeutics, GemPharmatech and Business Catalyst, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated solutions for next-generation antibody drug development are provided.
|
|
| domain | founded_year | HQ Location |
Provider of animal and cell line models as tools for drug discovery and diagnostics
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating multiple diseases
|
|
| domain | founded_year | HQ Location |
Humanized models and drug screening technologies are developed for research.
|
|
| domain | founded_year | HQ Location |
In-vivo mouse models are developed for biomedical R&D applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nagi Bioscience
Frequently Asked Questions about Nagi Bioscience
When was Nagi Bioscience founded?
Nagi Bioscience was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Nagi Bioscience located?
Nagi Bioscience is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Who is the current CEO of Nagi Bioscience?
Matteo Cornaglia is the current CEO of Nagi Bioscience. They have also founded this company.
Is Nagi Bioscience a funded company?
Nagi Bioscience is a funded company, having raised a total of $1.84M across 2 funding rounds to date.
What does Nagi Bioscience do?
Nagi Bioscience was founded in 2017 in Lausanne, Switzerland, within the biotechnology sector. An organism-on-a-chip platform is utilized, based on the nematode Caenorhabditis elegans, to enable in vivo assessments. Applications include drug discovery processes, toxicity evaluations, and screening of compounds for efficacy against parasitic worm infections. Operations focus on providing these testing services to support pharmaceutical and research needs.
Who are the top competitors of Nagi Bioscience?
Nagi Bioscience's top competitors include Biocytogen, Applied StemCell and GemPharmatech.
What products or services does Nagi Bioscience offer?
Nagi Bioscience offers SydLab™ One, Contract Laboratory Solutions, and Organism-on-Chip Technology.
Who are Nagi Bioscience's investors?
Nagi Bioscience has 4 investors. Key investors include Zurcher Kantonalbank, Nest Sammelstiftung, Verve Ventures, and MassChallenge.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.